24 HOUR WU ALLOCATION
| Research | Percent |
|---|---|
|
ALZHEIMERS |
89.39% |
|
CANCER |
4.55% |
|
ENZYME DYNAMICS |
3.03% |
|
EBOLA |
2.19% |
|
GRASPETIDE RING FORMATION |
.51% |
|
PEPTIDOMIMETIC CD40L BINDING |
.34% |
7 DAY WU ALLOCATION
| Research | Percent |
|---|---|
|
ALZHEIMERS |
91.4% |
|
CANCER |
2.94% |
|
ENZYME DYNAMICS |
2.08% |
|
EBOLA |
1.7% |
|
PLANT LIPID BIOSYNTHESIS MUTANTS |
.94% |
|
PEPTIDOMIMETIC CD40L BINDING |
.73% |
|
GRASPETIDE RING FORMATION |
.15% |
|
ATSTP10 TRANSPORT SIMULATION |
.06% |
12 WEEK WU ALLOCATION
| Research | Percent |
|---|---|
|
ALZHEIMERS |
71.67% |
|
ATGPA1 POST TRANSLATIONAL MODIFICATIONS |
4.89% |
|
ENZYME DYNAMICS |
4.87% |
|
CANCER |
3.41% |
|
EBOLA |
3.37% |
|
ATSTP10 SUCROSE TRANSPORT |
3.36% |
|
ATGPA1 POST TRANSLATIONAL MODIFICATION DYNAMICS |
2.24% |
|
RCA TEMPERATURE SIMULATIONS |
2.14% |
|
PLANT LIPID BIOSYNTHESIS MUTANTS |
1.74% |
|
PEPTIDOMIMETIC CD40L BINDING |
1.17% |
|
ATSTP10 TRANSPORT SIMULATION |
.68% |
|
GRASPETIDE RING FORMATION |
.17% |
|
ATWRI1 MUTANT SCREENING |
.08% |
|
MEMBRANE TRANSPORT |
.07% |
|
NIPAH VIRUS DECOY PROTEIN DYNAMICS |
.07% |
|
SUCROSE TRANSPORTER ATSUC1 |
.06% |